TBIQYR7548-Global Blood Cancer Drugs Market Research Report 2019
- TBI439228
- February 14, 2019
- Global
- 102 pages
- QY Market Research
Blood cancers, or hematologic cancers, affect the production and function of blood cells. Most of these cancers start in the bone marrow where blood is produced.
The global Blood Cancer Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of 10.0% during 2019-2025.
This report focuses on Blood Cancer Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood Cancer Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Amgen,
AstraZeneca PLC,
Astellas Pharma,
Bayer AG,
Bristol-Myers Squibb Company,
Celgene Corporation,
Eli Lilly,
F.Hoffmann-La Roche,
Johnson & Johnson,
Novartis
Pfizer,
Takeda Pharmaceutical Company Ltd,
AbbVie
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Blood Chemotherapy Drugs
Blood Targeted Therapy Drugs
Segment by Application
Leukemia
lymphoma
Multiple Myeloma
Table of Contents
Executive Summary
1 Blood Cancer Drugs Market Overview
1.1 Product Overview and Scope of Blood Cancer Drugs
1.2 Blood Cancer Drugs Segment by Type
1.2.1 Global Blood Cancer Drugs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Blood Chemotherapy Drugs
1.2.3 Blood Targeted Therapy Drugs
1.3 Blood Cancer Drugs Segment by Application
1.3.1 Blood Cancer Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Leukemia
1.3.3 lymphoma
1.3.4 Multiple Myeloma
1.3 Global Blood Cancer Drugs Market by Region
1.3.1 Global Blood Cancer Drugs Market Size Region
1.3.2 North America Status and Prospect (2014-2025)
1.3.3 Europe Status and Prospect (2014-2025)
1.3.4 China Status and Prospect (2014-2025)
1.3.5 Japan Status and Prospect (2014-2025)
1.3.6 Southeast Asia Status and Prospect (2014-2025)
1.3.7 India Status and Prospect (2014-2025)
1.4 Global Blood Cancer Drugs Market Size
1.4.1 Global Blood Cancer Drugs Revenue (2014-2025)
1.4.2 Global Blood Cancer Drugs Production (2014-2025)
2 Global Blood Cancer Drugs Market Competition by Manufacturers
2.1 Global Blood Cancer Drugs Production Market Share by Manufacturers (2014-2019)
2.2 Global Blood Cancer Drugs Revenue Share by Manufacturers (2014-2019)
2.3 Global Blood Cancer Drugs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Blood Cancer Drugs Production Sites, Area Served, Product Types
2.5 Blood Cancer Drugs Market Competitive Situation and Trends
2.5.1 Blood Cancer Drugs Market Concentration Rate
2.5.2 Blood Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Blood Cancer Drugs Production Market Share by Regions
3.1 Global Blood Cancer Drugs Production Market Share by Regions
3.2 Global Blood Cancer Drugs Revenue Market Share by Regions (2014-2019)
3.3 Global Blood Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Blood Cancer ...
| read more...
Related Reports
